Inscitech Meet on Genetics & Genome Research (IMGENETICS2026) is an international conference dedicated to showcasing the latest advancements, innovations, and research in the dynamic fields of Genetics and Genome Research. Scheduled to take place from June 15-17, 2026 in the vibrant city of Copenhagen, Denmark IMGENETICS2026 brings together leading academics, researchers, doctors, and industry professionals from around the globe.
Organized by InSciTech Summits, this three-day event provides a multidisciplinary platform for exchanging cutting-edge ideas, discussing real-world applications, and fostering collaborations across academia and industry. The program will feature plenary and keynote talks, technical sessions, interactive panels, and networking opportunities designed to inspire innovation and promote technological advancement.
Market Analysis- IMGENETICS2026
the genomics market is valued at approximately USD 59.28 billion and is projected to reach USD 118.67 billion by 2030, growing at a CAGR of 14.89%. Sub-segments such as genome sequencing and genomics services are also witnessing strong growth, with genome sequencing expected to rise from USD 26.31 billion in 2025 to USD 101.93 billion by 2034.
The personalized genomics segment is set to grow at an impressive CAGR of 17.73%, reaching over USD 52 billion by 2034. Key growth drivers include the adoption of next-generation and third-generation sequencing technologies, increased integration of artificial intelligence for data analysis, and a growing demand for personalized healthcare solutions. North America currently leads the market due to its robust healthcare infrastructure and investment in R&D, while the Asia-Pacific region is emerging rapidly, spurred by increasing healthcare expenditures and awareness. Notable trends include large-scale population genomics initiatives, ethical concerns surrounding consumer genomics data privacy (especially in light of events like the bankruptcy of 23andMe), and pioneering efforts in synthetic biology and de-extinction. Investment opportunities are abundant across diagnostics, therapeutics, agrigenomics, and bioinformatics platforms, although challenges such as regulatory complexities and data governance remain pivotal considerations for stakeholders
Best Regards,
Sara
Event Manager